News

Filter

Current filters:

febuxostat

1 to 9 of 21 results

Menarini extends febuxostat accord to more regions

12-04-2012

Japanese drugmaker Teijin Pharma and privately-owned Italian pharmaceutical company Menarini have signed…

febuxostatGenito-urinaryLicensingMenariniPharmaceuticalTeijin

Teijin and Astellas expand collaboration on gout drug febuxostat

12-08-2011

Japanese drugmakers Teijin Pharma (TYO: 3401 and Astellas Pharma (TKO:4503) have entered into an exclusive…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmafebuxostatLicensingPharmaceuticalTeijin

Ipsen grants Menarini exclusive European rights to Adenuric in up to 132 million-euro deal

20-10-2009

French specialty drugs firm Ipsen has entered into an agreement granting Italy’s Menarini Group…

Anti-Arthritics/RheumaticsEuropefebuxostatGeneralIpsenLicensingMenariniPharmaceuticalUloric

Teijin licenses febuxostat to Astellas in Taiwan

14-05-2009

Teijin Pharma has licensed TMX-67 (febuxostat), a drug for treating hyperuricemia in patients with gout,…

febuxostatUloric

Japan stock market week to March 16, 2009

23-03-2009

Tokyo rebounded after a four-week losing streak in the week ended March 16. The Nikkei 225 advanced 8.7%,…

allopurinolDoparDrug DiscoveryfebuxostatGilead SciencesGiliad SciencesGlaxoSmithKlineGSKLevodopaNystatinOralUloricZonegranZonisamideZyloprim

Japan stock market week to Feb 16, 2009

23-02-2009

Tokyo retreated in the week ended February 16 (four trading days only because February 11 was a national…

AstraZenecaCrestorfebuxostatrosuvastatinShionogiUloric

1 to 9 of 21 results

COMPANY SPOTLIGHT

Menarini

Back to top